ELI LILLY & Co·4

Feb 18, 4:22 PM ET

Zakrowski Donald A 4

4 · ELI LILLY & Co · Filed Feb 18, 2026

Research Summary

AI-generated summary of this filing

Updated

Eli Lilly (LLY) SVP Donald Zakrowski Exercises RSUs; Shares Withheld

What Happened
Donald A. Zakrowski, Senior Vice President, Finance & Chief Accounting Officer of Eli Lilly (LLY), had 184 restricted stock units convert to common shares on 2026-02-16 (reported as derivative exercise). No cash was paid for the conversion (price $0.00). To cover tax withholding, 81.553 of those shares were surrendered/withheld, with a reported withholding value of $84,815 (amounts reported at $1,040.00 per share). Net received from this vesting was 102.447 shares (184 − 81.553).

Key Details

  • Transaction date: 2026-02-16; Form 4 filed 2026-02-18 (timely; not flagged late).
  • Primary codes: M = exercise/conversion of derivative (RSU conversion); F = shares withheld to satisfy tax liability.
  • Shares converted: 184 RSUs → 184 shares at $0.00.
  • Shares withheld for taxes: 81.553 shares; reported value $84,815 (≈ $1,040.00/share).
  • Footnote: F1 notes the 81.553 share withholding amount includes 7.458 shares previously withheld to satisfy earlier tax obligations. F2 clarifies each RSU equals one share on vesting.
  • The filing does not state total shares owned following the transaction; net shares received from this vesting were 102.447 shares.

Context
This was a standard RSU vesting/conversion with shares withheld to cover taxes (a cashless tax withholding), not an open‑market sale or purchase. Such withholdings are routine administrative actions and do not by themselves indicate a change in the insider’s market view. The filing appears timely (filed two days after the reported transaction).

Insider Transaction Report

Form 4
Period: 2026-02-16
Zakrowski Donald A
SVP, Finance, & CAO
Transactions
  • Exercise/Conversion

    Common Stock

    2026-02-16+1843,607.443 total
  • Tax Payment

    Common Stock

    [F1]
    2026-02-16$1040.00/sh81.553$84,8153,525.89 total
  • Exercise/Conversion

    Restricted Stock Unit

    [F2]
    2026-02-161840 total
    From: 2026-02-16Exp: 2026-02-16Common Stock (184 underlying)
Holdings
  • Common Stock

    (indirect: By 401(k))
    1,728.57
Footnotes (2)
  • [F1]The reported amount includes 7.458 shares previously withheld to satisfy tax withholding obligations arising prior to the vesting date of this award.
  • [F2]Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock.
Signature
/s/ Jonathan Groff for Donald A. Zakrowski, pursuant to authorization on file|2026-02-18

Documents

1 file
  • 4
    wk-form4_1771449773.xmlPrimary

    FORM 4